A detailed history of Lpl Financial LLC transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 46,000 shares of TARA stock, worth $247,939. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,000
Previous 44,000 4.55%
Holding current value
$247,939
Previous $91,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$1.7 - $2.4 $3,400 - $4,800
2,000 Added 4.55%
46,000 $84,000
Q2 2024

Aug 07, 2024

BUY
$1.96 - $4.14 $31,360 - $66,240
16,000 Added 57.14%
44,000 $91,000
Q1 2024

May 10, 2024

BUY
$1.86 - $4.83 $29,760 - $77,280
16,000 Added 133.33%
28,000 $112,000
Q4 2023

Feb 14, 2024

BUY
$1.12 - $1.93 $2,240 - $3,860
2,000 Added 20.0%
12,000 $22,000
Q2 2023

Jul 31, 2023

SELL
$2.27 - $3.59 $56 - $89
-25 Reduced 0.25%
10,000 $23,000
Q1 2023

May 10, 2023

BUY
$2.76 - $3.91 $27,668 - $39,197
10,025 New
10,025 $31,000

Others Institutions Holding TARA

About Protara Therapeutics, Inc.


  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $60.7M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.